Litigation Details for Allergan, Inc. v. Somerset Therapeutics, LLC (D. Del. 2016)
✉ Email this page to a colleague
Allergan, Inc. v. Somerset Therapeutics, LLC (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-05-26 |
| Court | District Court, D. Delaware | Date Terminated | 2016-12-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 8,664,215 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Allergan, Inc. v. Somerset Therapeutics, LLC
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Allergan, Inc. v. Somerset Therapeutics, LLC (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-05-26 | 1 | assignee of U.S. Patent No. 8,664,215 (the “‘215 patent”). A copy of the ‘215 patent is attached as Exhibit… This is a civil action for patent infringement under the Patent Laws of the United States, 35 U.S.C…concerning the ‘215 patent to the FDA in connection with NDA No. 022134, identifying it as a patent “with respect… the expiration of the ‘215 patent will directly infringe the ‘215 patent under 35 U.S.C. §271(a), will… COMPLAINT FOR PATENT INFRINGEMENT filed against Somerset Therapeutics, LLC - Magistrate Consent | External link to document | |
| 2016-05-26 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,664,215 B2. (cna) (Entered:…2016 8 December 2016 1:16-cv-00392 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
